'''Ebselen''' (also called '''PZ 51''', '''DR3305''', and '''SPI-1005'''), is a synthetic organoselenium drug molecule with anti-inflammatory, anti-oxidant and cytoprotective activity. It acts as a mimic of [[glutathione peroxidase]] and can also react with [[peroxynitrite]].<ref>{{cite journal |author=Schewe T |title=Molecular actions of ebselen--an antiinflammatory antioxidant |journal=Gen Pharmacol |volume=26 |issue=6 |pages=1153–69 |year=1995 |pmid=7590103 |doi=10.1016/0306-3623(95)00003-J}}</ref> It is being investigated as a possible treatment for [[reperfusion injury]] and [[stroke]],<ref>{{cite journal |vauthors=Parnham M, Sies H |title=Ebselen: prospective therapy for cerebral ischaemia |journal=Expert Opin Investig Drugs |volume=9 |issue=3 |pages=607–19 |year=2000 |pmid=11060699 |doi=10.1517/13543784.9.3.607}}</ref><ref>{{cite journal |vauthors=Yamaguchi T, Sano K, Takakura K, Saito I, Shinohara Y, Asano T, Yasuhara H |title=Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group |url=http://stroke.ahajournals.org/cgi/content/full/29/1/12 |journal=Stroke |volume=29 |issue=1 |pages=12–7 |date=1 January 1998|pmid=9445321 |doi=10.1161/01.STR.29.1.12 }}</ref> [[hearing loss]] and [[tinnitus]],<ref>{{cite journal|title=Ebselen treatment reduces noise induced hearing loss via the mimicry and induction of glutathione peroxidase|journal=Hearing Research|volume=226|issue=1–2|pages=44–51|last1=Kil|first1=Jonathan|year=2007|last2=Pierce|first2=Carol|last3=Tran|pmid=17030476|first3=Huy|last4=Gu|first4=Rende|last5=Lynch|first5=Eric D|doi=10.1016/j.heares.2006.08.006}}</ref> and [[bipolar disorder]].<ref>{{Cite journal | last1 = Singh | first1 = N. | last2 = Halliday | first2 = A. C. | last3 = Thomas | first3 = J. M. | last4 = Kuznetsova | first4 = O. V. | last5 = Baldwin | first5 = R. | last6 = Woon | first6 = E. C. Y. | last7 = Aley | first7 = P. K. | last8 = Antoniadou | first8 = I. | last9 = Sharp | first9 = T. | last10 = Vasudevan | first10 = S. R. | last11 = Churchill | first11 = G. C. | title = A safe lithium mimetic for bipolar disorder | doi = 10.1038/ncomms2320 | journal = Nature Communications | volume = 4 | pages = 1332 | year = 2013 | pmid =  23299882| pmc =3605789 }}</ref><ref>{{cite web |url=http://www.ox.ac.uk/news/2013-01-08-new-drug-bipolar-disorder-may-offer-fewer-side-effects |title=New drug for bipolar disorder may offer fewer side effects |author=<!--Staff writer(s); no by-line.--> |date=2013-01-08 |work=[[University of Oxford]] Latest News |accessdate=12 January 2013}}</ref>
